Cagrilintide
Acylated 37-amino-acid amylin analogue with a C20 diacid chain via a gamma-glutamyl spacer; amylin and calcitonin receptor agonist.
From€630
€63 per vial · box of ten
In stock
Nova Peptides
Semaglutide
Synthetic 31-amino-acid analogue of human GLP-1 with Aib8 and Arg34 substitutions, acylated at Lys26.
Flat €25 shipping worldwide · free from €600 until 8 Nov.
In stock
One box = ten vials. Single vials are not sold.
Description
Semaglutide is supplied as a lyophilised powder for in vitro and laboratory research. Each box contains ten vials of the strength you select.
Every batch is produced under controlled laboratory conditions.
Vials are shipped lyophilised and are stable at room temperature during transit. For longer storage, keep vials sealed at -20 °C and protected from light. Once reconstituted, store refrigerated and use within the period your protocol specifies.
This product is supplied strictly for laboratory research use. It is not a drug, food or cosmetic, is not approved by any medicines agency, and is not intended for human or animal consumption, nor for diagnostic or therapeutic use.
References
Published, peer-reviewed research on this substance. The papers are about the substance itself and are not statements about this product.
Clinical trials
- Lincoff AM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. The New England journal of medicine. 2023. doi:10.1056/NEJMoa2307563 · PMID 37952131
- Bliddal H, et al. Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis. The New England journal of medicine. 2024. doi:10.1056/NEJMoa2403664 · PMID 39476339
- Weghuber D, et al. Once-Weekly Semaglutide in Adolescents with Obesity. The New England journal of medicine. 2022. doi:10.1056/NEJMoa2208601 · PMID 36322838
- Garvey WT, et al. Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity. The New England journal of medicine. 2025. doi:10.1056/NEJMoa2502081 · PMID 40544433
Pharmacology and pharmacokinetics
- Gabery S, et al. Semaglutide lowers body weight in rodents via distributed neural pathways. JCI insight. 2020. doi:10.1172/jci.insight.133429 · PMID 32213703
- Papakonstantinou I, Tsioufis K, Katsi V. Spotlight on the Mechanism of Action of Semaglutide. Current issues in molecular biology. 2024. doi:10.3390/cimb46120872 · PMID 39728000
- Knudsen LB, Lau J. The Discovery and Development of Liraglutide and Semaglutide. Frontiers in endocrinology. 2019. doi:10.3389/fendo.2019.00155 · PMID 31031702
- Yang XD, Yang YY. Clinical Pharmacokinetics of Semaglutide: A Systematic Review. Drug design, development and therapy. 2024. doi:10.2147/DDDT.S470826 · PMID 38952487
Reviews and safety assessments
- Smits MM, Van Raalte DH. Safety of Semaglutide. Frontiers in endocrinology. 2021. doi:10.3389/fendo.2021.645563 · PMID 34305810
- Bergmann NC, et al. Semaglutide for the treatment of overweight and obesity: A review. Diabetes, obesity & metabolism. 2023. doi:10.1111/dom.14863 · PMID 36254579
Product details
| Also known as | SEMA · NN9535 · GLP-1 analogue |
|---|---|
| Purity | ≥ 99% (HPLC) |
| Format | Lyophilised powder |
| Pack size | 10 vials per box |
| Storage | Sealed at -20 °C, protected from light |
| Storage (reconstituted) | 2–8 °C in the sealed vial, protected from light |
| Contents | Ten sealed vials of the same strength |
| Analysis | No analysis data is published for this product. |
Working out a dilution? How to reconstitute a peptide · Reconstitution calculator
Related products
MOTS-C
Mitochondrial-derived 16-amino-acid peptide encoded by a short open reading frame in the 12S rRNA gene MT-RNR1.
From€370
€37 per vial · box of ten
In stock
5-amino-1MQ
Small-molecule 5-amino-1-methylquinolinium salt, an NNMT inhibitor rather than a peptide.
From€300
€30 per vial · box of ten
In stock
Kisspeptin-10
C-terminally amidated decapeptide, residues 112-121 of the human KISS1 precursor, also called metastin 45-54.
From€330
€33 per vial · box of ten
In stockFrom €229
Semaglutide